Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

48.12
-0.5100-1.05%
Post-market: 48.130.0100+0.02%19:30 EDT
Volume:2.15M
Turnover:103.57M
Market Cap:97.33B
PE:15.39
High:48.59
Open:48.47
Low:47.98
Close:48.63
52wk High:61.70
52wk Low:39.29
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.82
T/O Rate:0.11%
Dividend:1.84
Dividend Rate:3.82%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.08
PE(LYR):12.88

Loading ...

GSK executives boost holdings via dividend-funded ADS purchases

TIPRANKS
·
Jul 16

GSK’s New Phase 3 Ovarian Cancer Trial Puts Mo-Rez in the First-Line Spotlight

TIPRANKS
·
Jul 16

Is AnaptysBio (ANAB) Undervalued Following Its Jemperli Royalty Appeal And GSK Trial?

Simply Wall St.
·
Jul 15

GSK Completes $10.6 Billion Acquisition of Nuvalent

MT Newswires Live
·
Jul 15

GSK Slides Tuesday, Underperforms Market

Dow Jones
·
Jul 15

GSK Executives Acquire Shares Under Routine Reward Plan

TIPRANKS
·
Jul 13

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 13

GSK’s Jemperli Trial Points to Chemo‑Free Future for Subset of Rectal Cancer Patients

TIPRANKS
·
Jul 13

J.P. Morgan Sticks to Their Sell Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 13

Guggenheim Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jul 10

GSK says Hansoh Pharma announces positive phase 3 results for Ris-Rez in China

TIPRANKS
·
Jul 10

Revenue Revision at Frontier Biotech Highlights Channel Pressures as Operating Losses Widen

Deep News
·
Jul 10

GSK price target raised to 1,950 GBp from 1,900 GBp at Deutsche Bank

TIPRANKS
·
Jul 10

GSK US President Acquires Notional ADS Under Executive Savings Plan

TIPRANKS
·
Jul 09

GSK Adds Philips CEO Roy Jakobs to Board as Independent Director

TIPRANKS
·
Jul 09

SBP GROUP Shares Surge Over 5% in Early Trading on Deepened Strategic Alliance with GLAXOSMITHKLINE

Deep News
·
Jul 09

Alector Ends GSK Collaboration, Retires Hercules Capital Debt

TIPRANKS
·
Jul 09

GSK’s New RSV/hMPV Vaccine Trial Adds Momentum to Its Respiratory Portfolio

TIPRANKS
·
Jul 09

GSK Targets Pediatric Vaccine Growth With New Phase 3 Trial Against Merck’s ProQuad

TIPRANKS
·
Jul 09

GSK Advances Novel Malaria Drug Into Phase 2A, Signaling Long-Term Global Health Upside

TIPRANKS
·
Jul 09